Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets

Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets

Although there are existing vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), new COVID-19 cases are increasing due to low immunization coverage and the emergence of new variants. For this reason, new drugs to treat and prevent severe COVID-19 are needed. Here, we provid...

Full description

Bibliographic Details
Main Authors: Luis C. Vesga, Camilo A. Ruiz-Hernández, Jeimmy J. Alvarez-Jacome, Jonny E. Duque, Bladimiro Rincon-Orozco, Stelia C. Mendez-Sanchez
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Scientia Pharmaceutica
Subjects:
repurposing drugs
COVID
SARS-CoV-2
molecular docking
Online Access:https://www.mdpi.com/2218-0532/90/2/24

Similar Items

Similar Items